Skip to main content

Adenovirus Vectors for Gene Therapy

  • Chapter
Gene Therapy
  • 237 Accesses

Abstract

In the fast growing area of vector systems, one of the most advanced is the replication deficient-recombinant adenovirus (Ad vector). It is remarkably efficient at transferring genes to a wide variety of target cells in vitro and in vivo and at ex­pressing exogenous genes at a high level [Crystal, 1995; Horwitz, 1996]. After in­fection, the Ad vector expresses the transgene in the nucleus of replicating and non-replicating cells in an epi-chromosomal fashion, where the duration of gene expres­sion is transient over time [Rosenfeld et al., 1991; Kass-Eissler et al., 1994; Smith et al., 1993; Engelhard et al., 1994; Yang et al., 1994a, b].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adam, E., Nasz, I. and Lengyel, A. (1995) Antigenic homogenicity among the adenovirus hexon types of the subgroup C. Arch. Virol. 140: 1297–1301.

    Article  PubMed  CAS  Google Scholar 

  • Anderson, K. and Fennie, E. (1987) Adenovirus early region la modulation of interferon antiviral activity. J. Virol. 61: 787–795.

    PubMed  CAS  Google Scholar 

  • Anderson, W. F. (1992) Human gene therapy. Science 256: 808–813.

    Article  PubMed  CAS  Google Scholar 

  • Barr, D., Tubb, J., Ferguson, D., Scaria, A., Lieber, A., Wilson, C., Perkins, J. and Kay, M. A. (1995) Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2: 151–155.

    PubMed  CAS  Google Scholar 

  • Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong,.J.S., Horwitz, M. S., Crowell, R. L. and Finberg R.W. (1997) Isolation of a common receptor for coxsackie B virus and adenovirus 2 and 5. Science 275: 1320–1323.

    CAS  Google Scholar 

  • Berkner, K. L. and Sharp, P. A. (1983) Generation of adenovirus by transfection of plasmids. Nucl. Acid. Res. 10: 6003–6020.

    Article  Google Scholar 

  • Berkner, K. L. (1988) Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6: 616–629.

    Article  PubMed  CAS  Google Scholar 

  • Bett, A. J., Haddara, W., Prevec, L. and Graham, E L. (1994) An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91: 8802–8806.

    Article  PubMed  CAS  Google Scholar 

  • Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., McCormick, F. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274: 373–376.

    Article  PubMed  CAS  Google Scholar 

  • Burgert, H. G. and Kvist, S. (1987) The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J. 6: 2019–26.

    PubMed  CAS  Google Scholar 

  • Cai, D. W., Mukhopadhyay, T. Liu, Y., Fujiwara, T. and Roth, J. (1993) Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. Hum. Gene Ther. 4: 617–624.

    CAS  Google Scholar 

  • Chroboczek, J., Bieber, E, Jacrot B. (1992) The sequence of the genome of adenovirus type 5 and its comparison with the genome of the adenovirus type 2. Virology 186: 280–285. Collins, F. S. (1992) Cystic fibrosis: Molecular biology and therapeutic implications. Science 256: 774–779.

    Article  Google Scholar 

  • Crystal, R. G. (1995) Transfer of genes to humans: Early lessons and obstacles to success. Science 270: 404–410.

    Article  PubMed  CAS  Google Scholar 

  • Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C. S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T. and Danel, C. (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8: 42–51.

    Article  PubMed  CAS  Google Scholar 

  • Culver, K. M., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H. and Blase, R. M. (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550–1552.

    CAS  Google Scholar 

  • Dai, Y., Schwarz, E. M., Gu, D., Zhang, W. -W., Sarvetnik, M. and Verma, I. M. (1995) Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long term expression. Proc. Natl. Acad. Sci. USA 92: 1401–1405.

    Article  PubMed  CAS  Google Scholar 

  • Deonarain, M. P., Spooner, R.A and Epenetos, A. A. (1995) Genetic delivery of enzymes for cancer therapy. Gene Ther. 2: 235–244.

    PubMed  CAS  Google Scholar 

  • Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M. and Curiel, T., (1996) Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotechnol. 14: 1574–1578.

    Article  PubMed  CAS  Google Scholar 

  • Eissa, N. T., Chu, C. S., Danel, C. and Crystal, R. G., (1994) Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus Ela sequences relevant to the use of Ela-adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis. Hum. Gene Ther. 5: 1105–1114.

    Article  PubMed  CAS  Google Scholar 

  • Engelhardt, J. E, Ye, X., Doranz, B. and Wilson, J. M. (1994) Ablation of E2A in recombinant adenovirus improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91: 6196–6200.

    Article  PubMed  CAS  Google Scholar 

  • Enders, J. E, Bell, J. A., Dingl,e J.H. (1956) “Adenoviruses” group name proposed for new respiratory-tract viruses. Science 124: 119–120.

    Google Scholar 

  • Fisher, K.J., Mikheeva, G. V., Douglas, J. T. and Curiel, D. T. (1996) Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. Virology 70: 6839–6846.

    Google Scholar 

  • Friedmann, T. (1996) Human gene therapy — an immature genie, but certainly out of the bottle. Nat. Med. 2: 144–147.

    Article  PubMed  CAS  Google Scholar 

  • Gao, G. -P., Yang, Y. and Wilson, J.M: (1996) Biology of adenovirus vectors with E1A and E4 deletions for liver-directed gene therapy. J. Virol. 70: 8934–8943.

    PubMed  CAS  Google Scholar 

  • Gooding, L. R., Ranheim, T. S., Tollefson, A. E., Aquino, L., Duerksen-Hughes, P., Horton, T. M., Wold, W. S. (1991) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65: 4114–23.

    PubMed  CAS  Google Scholar 

  • Graham, F. L. and Prevec, L. (1991) Manipulation of adenovirus vectors. In: E. J. Murray (ed.), Methods in Molecular Biology. The Humana Press, Clifton, NY, pp. 109–128.

    Google Scholar 

  • Graham, F. L., Smiley, J., Russell, W. C. and Nairn, R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36: 59–74.

    Article  PubMed  CAS  Google Scholar 

  • Greber, U. E, Willetts, M., Webster, P. and Helenius, A. (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477–486.

    Article  PubMed  CAS  Google Scholar 

  • Green, M., Wold, W. S. M. and Brachmann, K. H. (1980) Human adenovirus transforming genes: group relationships, integration, expression in transformed cells and analysis of human cancers and tonsils. In: M. Essex, G. Todaro, H. zur Hausen H (eds), Cold Spring Habor conference on cell proliferation viruses in naturally ocuring tumors. Cold Spring Habor Laboratory, Cold Spring Habor, NY., pp. 373–397.

    Google Scholar 

  • Hehir, K. M., Armentano, D., Cardoza, L. M., Choquette, T. L., Berthelette, P. B., White, G. A., Courture, L. A., Everton, M. B., Keegan, J., Mertin, J. M., Pratt, D. A., Smith, M. P., Smith, A. E. and Wadsworth, S. C. (1996) Molecular Characterization of replication competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J. Virol. 70: 8459–8467.

    PubMed  CAS  Google Scholar 

  • Hillemann, M. R. and Werner, J. R. (1953) Recovery of a new agent from patients with acute respiratory illness. Proc. Soc. Exp. Biol. Med. 85: 574–580.

    Google Scholar 

  • Human gene marker/therapy clinical protocols (completed and uptated listing) (1996) Hum. Gene Ther. 18: 2287–2313.

    Google Scholar 

  • Horwitz, M. S. (1996) Adenoviridae and their replication. In: B. N. Fields and D. M. Knipe (eds), Virology. Raven Press, New York, pp 1679–1740.

    Google Scholar 

  • Horwitz, M. S. (1996) Adenoviruses. In: B. N. Fields and D. M. Knipe (eds), Virology. Raven Press, New York, pp. 2149–2171.

    Google Scholar 

  • Imperiale, M. J., Kao, H. -T. Feldmann, L. T., Nevins, J. R. and Strickland, S. (1984) Common control of the heat shock gene and early adenovirus genes for a cellular Ela-like activity. Mol. Cell. Biol. 4: 867–874.

    PubMed  CAS  Google Scholar 

  • Kao, C. C., Yew, P. R., Berk, A. J. (1990) Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 179: 806–14.

    Article  PubMed  CAS  Google Scholar 

  • Kass-Eisler, A., Falck-Pedersen, E., Elfenbein, D. H., Alvira, M., Buttrick, P. M. and Leinwand, L. A. (1994) The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1: 395–402.

    PubMed  CAS  Google Scholar 

  • Kay, M. A., Holterman, A. X., Meuse, L., Gown, A., Ochs, H. D., Linsley, P. S. and Wilson, C. B. (1995) Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11: 191–197.

    Article  PubMed  CAS  Google Scholar 

  • Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M. and Tsui, L. C. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073–1080.

    Article  PubMed  CAS  Google Scholar 

  • Kitajewski, J., Schneider, R. J., Safer, B., Munemitsu, S. M., Samuel, C. E., Thimmappaya, B. and Shenk, T. (1986) Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 45: 195–200.

    Article  PubMed  CAS  Google Scholar 

  • Knowles, M. R., Hohneker, K. W., Zhou, Z., Olsen, J. C., Noah, T. L., Hu, P. C., Leigh, M. W., Engelhardt, J. F., Edwards, L. J., Jones, K. R., et-al (1995) A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333: 823–831.

    Article  PubMed  CAS  Google Scholar 

  • Kochanek, St., Clemens, P. R., Mitani, K., Chen, H. -H., Chan, S. and Caskey, C. T. (1996) A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and (3-Galactosidase. Proc. Natl. Acad. Sci. USA 93: 5731–5736.

    Article  PubMed  CAS  Google Scholar 

  • Krishna, J., Choi, H., Burda, J., Chen, S. -J. and Wilson, J. M. (1996) Recombinant Adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. J. Virol. 217: 11–22.

    Article  Google Scholar 

  • Krougliak, V. and Graham, F. L. (1995) Development of cell lines capable of complementing E1A, and protein IX defective adenovirus type 5 mutants. Hum. Gene Ther. 6: 1575–1586.

    Article  PubMed  CAS  Google Scholar 

  • Lochmuller, H., Jani, A., Huard, J., Prescott, S., Simoneau, M., Massie, B., Karpati, G., Acsadi, G. (1994) Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum. Gene Ther. 5: 1485–1491.

    Article  PubMed  CAS  Google Scholar 

  • Mack, C. A., Song, W. R. Carpenther, H., Wickham, T. J., Kovesdi, I., Harvey, B. G., Macgovern, C. J., Isom, O. W., Rosengart, T., Falck-Pedersen, E., Hackett, N. R., Crystal, R. G. and Mastrangeli, A. (1997) Circumvention of anti adenovirus neutralizing immunity by administration of an adenoviral vector of an alternative serotype. Hum. Gene Ther. 8: 99–109.

    Article  PubMed  CAS  Google Scholar 

  • Maizel, J. V., White, J. D. and Scharff, M. D. (1968) The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7a and 12. Virology 36: 115–125.

    Article  PubMed  CAS  Google Scholar 

  • Mastrangeli, A., Harvey, B. G., Yao, J., Wolff, G., Kovesdi, I., Crystal, R. G. and FalckPedersen, E. (1996) “Sero-switch” adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defence against repeat adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 7: 79–87.

    Google Scholar 

  • Michael, S. I., Hong, J. S., Curiel, D. T. and Engler, J. A. (1995) Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2: 660–668.

    PubMed  CAS  Google Scholar 

  • Mittereder, N., March, K. L. and Trapnell, B. C. (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70: 7498–7509.

    PubMed  CAS  Google Scholar 

  • Moolten, F. L. (1994) Drug sensitivity (“suicide”) genes for selective cancer therapy. Cancer Gene Ther. 1: 279–287.

    CAS  Google Scholar 

  • Mullbacher, A., Bellett, A. J. and HLA, R.T (1989) The murine cellular immune response to adenovirus type 5. Immunol. Cell. Biol. 67: 31–39.

    Article  PubMed  Google Scholar 

  • Mulligan, R. C. (1993) The basic science of gene therapy. Science 260: 926–32.

    Article  PubMed  CAS  Google Scholar 

  • Munaf, A., Lemoine, N. R. and Ring, J. A. (1994) The use of DNA viruses as vectors for gene therapy. Gene Ther. 1: 367–384.

    Google Scholar 

  • Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Playsic, N., Chou, J. L., Drumm, M. L., Iannuzzi, M. C., Collins, E S. and Tsui, L. P. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066–1073.

    Article  PubMed  CAS  Google Scholar 

  • Roberts, RJ, O’Neill, KE, Yen, CT. (1984) DNA sequences from the adenovirus 2 genome. J. Biol. Chem. 259: 13968–13975.

    PubMed  CAS  Google Scholar 

  • Rommens, J. M., Iannuzzi, M. C., Kerem, B., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N.,Zsiga, M., Buchwald, M., Riordan, J. R., Tsui, L. C. and Collins, F. S. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059–1065.

    CAS  Google Scholar 

  • Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Paakko, P. K., Gilardi, P., Stratford-Pericaudet, L. D., Pericaudet, M., Jallat, S., Pavirani, A., Lecocq, J. -P. and Crystal, R. G. (1991) Adenovirus-mediated gene transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252: 431–434.

    CAS  Google Scholar 

  • Rosenfeld, M. A., Yoshimura, K., Trapnell,B.C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Pericaudet, L. D., Pericaudet, M., Guggino, W. B., Pavirani, A., Lecocq, J. -P. and Crystal, R. G. (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143–155.

    CAS  Google Scholar 

  • Roth, J. A. (1996) Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wild-type p53 and cisplatin. Hum. Gene Ther. 7: 1013–1030.

    Article  PubMed  CAS  Google Scholar 

  • Rowe, W. P., Huebner, R. J., Gilmore, R. J., Parrott, R. N., Ward, T. G. (1953) Isolation of a cytpathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med. 84: 570–573.

    PubMed  CAS  Google Scholar 

  • Seth, P., Fitzgerald, D. J., Willingham, M. C., Pastan, I. (1984) Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate. J. Virol. 51: 650–655.

    PubMed  CAS  Google Scholar 

  • Shenk, T. (1996) Adenoviridiae: The viruses and their replication. In: B. N. Fields and D. M. Knipe (eds), Virology. Raven Press, New York, pp. 2149–2171.

    Google Scholar 

  • Smith, T. A. G., Mehaffey, M. G., Kayda D.B., Saunders, J. M., Yei, S., Trapnell, B. C., McClelland, A. and Kaleko, M. (1993) Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5: 397–402.

    Article  PubMed  CAS  Google Scholar 

  • Spergel, J. and Cheng-Kiang, S. (1991) Interleukin 6 enhances a cellular activity that functionally substitutes for Ela protein in transactivation. Proc. Natl. Acad. Sci. USA 88: 6472–6476.

    Article  PubMed  CAS  Google Scholar 

  • Trentin, J. J., Yabe, Y, Taylor, G. (1962) The quest for human cancer viruses. Science 137: 835–849.

    Article  PubMed  CAS  Google Scholar 

  • Thummel, C, Tjian, R., Hu, S. L. and Grodzicker T. (1983) Translation control of SV40 T antigen expressed from the adenovirus late promotor. Cell 33: 455–464.

    Article  PubMed  CAS  Google Scholar 

  • Wohlfahrt, C. E., Svenssson, U. K. and Everitt, E. (1985) Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera. J. Virol. 56: 896–903.

    Google Scholar 

  • Wohlfahrt, C. E. (1988) Neutralization of adenoviruses: kinetics,stoichiometry, and mechanisms. J. Virol. 62: 2321–2328.

    Google Scholar 

  • Wickham, T. J., Mathias, P., Cheresh, D. A. and Nemerow, G. R., (1993) Integrins alpha AT beta 3 and alpha IT beta 5 promote adenovirus internalization but not virus attachment. Cell 73: 309–319.

    Article  PubMed  CAS  Google Scholar 

  • Wickham, T. J. Carrion, M. E. and Kovesdi, I. (1995) Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2: 750–756.

    PubMed  CAS  Google Scholar 

  • Wickham, T. J., Roelvink, P. W., Brough, D. E. and Kovesdi, I. (1996a) Adenovirus targeted to heparan containing receptors increase its gene delivery efficiency to multiple cell types. Nature-Biotechnol. 14: 1570–1573.

    Article  CAS  Google Scholar 

  • Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M. and Kovesdi, I. (1996b) Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70: 6831–8.

    PubMed  CAS  Google Scholar 

  • Wolff, G., Worgall, S., Rooijen, N. van, Song, W. -R., Harvey, B. -G. and Crystal, R. G. (1997) Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J. Virol. 71: 624–629.

    PubMed  CAS  Google Scholar 

  • Worgall, S., Wolff, G., Falck-Pedersen, E. and Crystal, R. G. (1997) Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8: 37–44.

    Article  PubMed  CAS  Google Scholar 

  • Xu, M., Kumar, D., Srinivas, S., Detolla, L. J., Yu, S. F., Stass, S. A. and Mixson, A. J. (1997) Parenteral Gene therapy with p53 inhibits human breast cancer tumors in vivo through a bystander mechanism without evidence of toxicity. Hum. Gene Ther. 8: 177–185.

    Article  PubMed  CAS  Google Scholar 

  • Yang, Y. and Wilson, J. M. (1995) Clearence of adenovirus-infected hepatocytes by MHC class-I restricted CD4+ CTLs in vivo. J. Immunol. 155: 2564–2570.

    CAS  Google Scholar 

  • Yang, Y., Ertl, H. C. and Wilson, J. M. (1994a) MHC class-I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1: 433–442.

    Article  PubMed  CAS  Google Scholar 

  • Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E. and Wilson, J. M. (1994b) Cellular Immunity to viral antigens limits El deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407–4411.

    Article  PubMed  CAS  Google Scholar 

  • Yang, Y., Li, Q., Ertl. H.C.J. and Wilson, J. M. (1995a) Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004–2015.

    CAS  Google Scholar 

  • Yang, Y., Trinchieri, G. and Wilson J.M. (1995b)Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1: 890–893.

    Google Scholar 

  • Yang, Y. Xiang, Z., Ertl, H. C. and Wilson, J. M. (1995c) Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92: 7257–7261.

    Article  PubMed  CAS  Google Scholar 

  • Yew, P. R. and Berk, A. J. (1992) Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357: 82–5.

    Article  PubMed  CAS  Google Scholar 

  • Zabner, J., Couture, L. A., Gregory, R. J., Graham, S. M., Smith, A. E. and Welsh, M. J. (1993) Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75: 207–216.

    Article  PubMed  CAS  Google Scholar 

  • Zabner, J., Petersen, D. M., Puga, A. P., Graham, S. M., Couture, L. A., Keyes, L. D., Lukason, M. J., St.George, J. A., Gregory, R. J., Smith, A. E. and Welsh, M. J. (1994) Safety and efficiacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet. 6: 75–83.

    CAS  Google Scholar 

  • Zilli, D., Voelkel-Johnson, C., Skinner, T;. and Laster, S. M. (1992) The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid. Biochem. Biophys. Res. Commun. 188: 177–183.

    CAS  Google Scholar 

  • Zinkernagel, R. M. (1996) Immunology taught by viruses. Science 271: 173–178.

    Google Scholar 

  • Zsengeller, Z. K., Wert, S. E., Hull, W. M., Hu, X., Yei, S., Trapnell, B. C. and Whitsett, J. A. (1995) Peristence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6: 457–467.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Birkhäuser Verlag Basel

About this chapter

Cite this chapter

Wolff, G. (1999). Adenovirus Vectors for Gene Therapy. In: Blankenstein, T. (eds) Gene Therapy. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7011-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7011-5_3

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-0348-7013-9

  • Online ISBN: 978-3-0348-7011-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics